Journalartikel

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine


AutorenlisteAhlén, G; Frelin, L; Nikouyan, N; Weber, F; Höglund, U; Larsson, O; Westman, M; Tuvesson, O; Gidlund, EK; Cadossi, M; Appelberg, S; Mirazimi, A; Sällberg, M

Jahr der Veröffentlichung2020

ZeitschriftJournal of Virology

Bandnummer94

Heftnummer18

ISSN0022-538X

eISSN1098-5514

Open Access StatusHybrid

DOI Linkhttps://doi.org/10.1128/JVI.01279-20

VerlagAmerican Society for Microbiology



Zitierstile

Harvard-ZitierstilAhlén, G., Frelin, L., Nikouyan, N., Weber, F., Höglund, U., Larsson, O., et al. (2020) The SARS-CoV-2 N Protein Is a Good Component in a Vaccine, Journal of Virology, 94(18), Article e01279-20. https://doi.org/10.1128/JVI.01279-20

APA-ZitierstilAhlén, G., Frelin, L., Nikouyan, N., Weber, F., Höglund, U., Larsson, O., Westman, M., Tuvesson, O., Gidlund, E., Cadossi, M., Appelberg, S., Mirazimi, A., & Sällberg, M. (2020). The SARS-CoV-2 N Protein Is a Good Component in a Vaccine. Journal of Virology. 94(18), Article e01279-20. https://doi.org/10.1128/JVI.01279-20



Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 11:15